Gene · 7112
Papers1,529
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,529
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription. | Exp Mol Med | 2022 | 35760875 | PubTator, text mining | PubMed |
| Analysis and pharmacological modulation of senescence in human epithelial stem cells. | J Cell Mol Med | 2022 | 35706382 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Construction of a Metabolism-Related Long Non-Coding RNAs-Based Risk Score Model of Hepatocellular Carcinoma for Prognosis and Personalized Treatment Prediction. | Pathol Oncol Res | 2022 | 35685867 | PubTator, text mining | PubMed |
| Proteomic Analysis of Lung Cancer Types-A Pilot Study. | Cancers (Basel) | 2022 | 35681609 | PubTator, text mining | PubMed |
| LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | BMC Cancer | 2022 | 35676659 | PubTator, text mining | PubMed |
| Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer. | World J Surg Oncol | 2022 | 35650630 | PubTator, text mining | PubMed |
| Fluctuations in Corneal Endothelial LAP2 Expression Levels Correlate with Passage Dependent Declines in Their Cell Proliferative Activity. | Int J Mol Sci | 2022 | 35628669 | PubTator, text mining | PubMed |
| The Involvement of Long Non-Coding RNAs in Glioma: From Early Detection to Immunotherapy. | Front Immunol | 2022 | 35619711 | PubTator, text mining | PubMed |
| A Systematic Pan-Cancer Analysis of CASP3 as a Potential Target for Immunotherapy. | Front Mol Biosci | 2022 | 35573727 | PubTator, text mining | PubMed |
| Transcription Factor Lmx1b Negatively Regulates Osteoblast Differentiation and Bone Formation. | Int J Mol Sci | 2022 | 35563615 | PubTator, text mining | PubMed |
| Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling. | Int J Mol Sci | 2022 | 35563538 | PubTator, text mining | PubMed |
| Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma. | Respir Res | 2022 | 35562727 | PubTator, text mining | PubMed |
| The transcription factor PREP1(PKNOX1) regulates nuclear stiffness, the expression of LINC complex proteins and mechanotransduction. | Commun Biol | 2022 | 35550602 | PubTator, text mining | PubMed |
| Pancreatic INS-1 β-Cell Response to Thapsigargin and Rotenone: A Comparative Proteomics Analysis Uncovers Key Pathways of β-Cell Dysfunction. | Chem Res Toxicol | 2022 | 35544339 | PubTator, text mining | PubMed |
| Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization. | Toxicol In Vitro | 2022 | 35537566 | PubTator, text mining | PubMed |
| Mechanics and functional consequences of nuclear deformations. | Nat Rev Mol Cell Biol | 2022 | 35513718 | PubTator, text mining | PubMed |
| The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside. | J Ginseng Res | 2022 | 35509820 | PubTator, text mining | PubMed |
| Nuclear pore complexes - a doorway to neural injury in neurodegeneration. | Nat Rev Neurol | 2022 | 35488039 | PubTator, text mining | PubMed |
| Esophageal squamous cell carcinoma: Integrated bioinformatics analysis for differential gene expression with identification of hub genes and lncRNA. | Biochem Biophys Rep | 2022 | 35479061 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7112/papers?page=12